ABSTRACT NUMBER: ESOC2026A818 THE HOMEOSTASIS-BASED PROTOCOL TO FREEZE PENUMBRA IN ISCHEMIC STROKE PATIENTS

Abstract Background and aims The use of reperfusion therapies is ineffective in almost half of the acute ischemic stroke (AIS) patients. Maintaining homeostasis and cytoprotection is a rational starting point for developing a bundle of interventions to improve AIS outcomes. Methods We provide the protocol (“TAKE 5”) that integrates several approaches: optimizing body temperature, maintaining water balance to achieve an optimal mean arterial pressure (MAP), ensuring metabolic and ionic homeostasis, and providing cytoprotection. Results Several studies provide evidence supporting “TAKE 5” protocol: 1/stabilization of the body temperature. A robust meta-analysis indicates that paracetamol given to patients with AIS is safe and reduces early mortality, 2/restoration of the water balance and stable MAP. Higher MAP lowers the NIHSS (7 points for each 10mmHg up to 90mmHg). Considering the correlation with vascular measures, one may tend to use MAP=[DBP]+0.412×[PP] formula that we compared with the other formulas. 3/Metabolic stabilization i.e. optimal glycemia. 4/Correction of magnesium depletion using MgSO4. It is safe, potentially beneficial, and can be easily added to buffered crystalloids to correct fluid deficits. 5/Cytoprotection protects against or reduce the consequences of reperfusion injury and improves treatment outcomes. Cerebrolysin is a preparation with potential cytoprotective action and supports the neurorehabilitation of patients in the AIS. We present the clinical improvement in patients with Cerebrolysin as add-on to reperfusion. Conclusions The Homeostasis-Based Protocol (“TAKE5”) can be successfully applied in all AIS patients, particularly during the pre-recanalization phase (before/during transportation to the thrombectomy center) or directly after reperfusion therapy. Conflict of interest Slawomir Michalak.nothing to disclose. Michal Karlinski.nothing to disclose. Jacek staszewski.nothing to disclose.

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.1421
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A818 THE HOMEOSTASIS-BASED PROTOCOL TO FREEZE PENUMBRA IN ISCHEMIC STROKE PATIENTS

S Miсhalak, Michał Karliński, Jacek Staszewski
European Stroke Journal
Acute Ischemic Stroke Management
article

ABSTRACT NUMBER: ESOC2026A818 THE HOMEOSTASIS-BASED PROTOCOL TO FREEZE PENUMBRA IN ISCHEMIC STROKE PATIENTS

S Miсhalak, Michał Karliński, Jacek Staszewski
article en

Abstract

Abstract Background and aims The use of reperfusion therapies is ineffective in almost half of the acute ischemic stroke (AIS) patients. Maintaining homeostasis and cytoprotection is a rational starting point for developing a bundle of interventions to improve AIS outcomes. Methods We provide the protocol (“TAKE 5”) that integrates several approaches: optimizing body temperature, maintaining water balance to achieve an optimal mean arterial pressure (MAP), ensuring metabolic and ionic homeostasis, and providing cytoprotection. Results Several studies provide evidence supporting “TAKE 5” protocol: 1/stabilization of the body temperature. A robust meta-analysis indicates that paracetamol given to patients with AIS is safe and reduces early mortality, 2/restoration of the water balance and stable MAP. Higher MAP lowers the NIHSS (7 points for each 10mmHg up to 90mmHg). Considering the correlation with vascular measures, one may tend to use MAP=[DBP]+0.412×[PP] formula that we compared with the other formulas. 3/Metabolic stabilization i.e. optimal glycemia. 4/Correction of magnesium depletion using MgSO4. It is safe, potentially beneficial, and can be easily added to buffered crystalloids to correct fluid deficits. 5/Cytoprotection protects against or reduce the consequences of reperfusion injury and improves treatment outcomes. Cerebrolysin is a preparation with potential cytoprotective action and supports the neurorehabilitation of patients in the AIS. We present the clinical improvement in patients with Cerebrolysin as add-on to reperfusion. Conclusions The Homeostasis-Based Protocol (“TAKE5”) can be successfully applied in all AIS patients, particularly during the pre-recanalization phase (before/during transportation to the thrombectomy center) or directly after reperfusion therapy. Conflict of interest Slawomir Michalak.nothing to disclose. Michal Karlinski.nothing to disclose. Jacek staszewski.nothing to disclose.

European Stroke JournalVol. 11(Supplement_1)
Poznan University of Medical Sciences (PL), National Academy of Medicine (US), Wojskowy Instytut Medycyny Lotniczej (PL), Institute of Psychiatry and Neurology (PL), Narodowy Instytut Leków (PL)
Clean water and sanitation
Openalex Percentile: Top 9%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.